Santaris Pharma
Latest round
- Series C
Last raised
- Dec 2007
Total raised
- $35M
Investors
- 13
About Santaris Pharma
Founded in 2003, Santaris Pharma focuses on RNA-targeted therapies. The company was acquired by Roche in August 2014 for USD 450 mn.Santaris Pharma develops RNA-targeted therapeutics aimed at treating diseases through innovative mechanisms.Following its acquisition by Roche, Santaris Pharma is expected to leverage resources for the development of new RNA-targeted products. The focus includes expanding into new markets, particularly in North America and Europe, with plans to enhance their product pipeline in the coming years.
Who invested in Santaris Pharma
13 investors across 2 rounds
See all investors in Santaris Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Santaris Pharma
Who invested in Santaris Pharma?
Santaris Pharma has 13 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Santaris Pharma raised?
Santaris Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Santaris Pharma last raise money?
Santaris Pharma's most recent round on record is a Series C, in Dec 2007.
What does Santaris Pharma do?
Founded in 2003, Santaris Pharma focuses on RNA-targeted therapies.
Where is Santaris Pharma headquartered?
Santaris Pharma is headquartered in Denmark.
Which VCs invest in companies like Santaris Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Santaris Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Santaris Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.